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Background and objective: Whereas nutrition deficits are recognized as an expression of 
systemic inflammation in the elderly with diagnosed chronic obstructive pulmonary disease 
(COPD), if they occur in symptomatic elderly smokers, unfulfilled COPD criteria are not 
confirmed.
Methods: Respiratory function, anthropometry assessment, and diet intake evaluation of 
13 COPD patients (COPD group), ten symptomatic elderly smokers (SYSM group), and 27 
healthy volunteers (control group) were compared. All were 70 years old or older.
Results: The SYSM group had lower body weight, body mass index, percentage ideal body 
weight, body fat percentage, arm muscle circumference, tricep skin fold thickness, serum 
  albumin, prealbumin, and transferrin than the control group and were similar to the COPD 
group (P , 0.05 each and nonsignificant each). Resting energy expenditure was no different 
among the groups. Intake of energy, vitamins (A, B1, B2, and C), calcium, iron, fiber, and 
sodium was also lower in the SYSM group than in the control group (P , 0.05 all) and was 
similar to the COPD group.
Conclusion: Elderly smokers who are symptomatic but who do not fulfill the COPD diagnostic 
criteria have nutritional deficits related to insufficient energy intake that are similar to those 
seen in COPD patients.
Keywords: chronic obstructive pulmonary disease (COPD), nutritional status, body composition, 
resting energy expenditure (REE)
Introduction
Chronic obstructive pulmonary disease (COPD) is an airway inflammatory disease 
caused by inhalation of toxic particles, mainly cigarette smoking, and is now accepted 
as a disease associated with systemic characteristics.1 Nutritional status is one of them. 
Twenty-six percent to 70 percent of COPD patients with the disease have malnutrition.2,3 
In the Global Initiative for Chronic Obstructive Lung Disease, which was revised in 
2006, however, the malnutrition is considered to be developed only in moderate or severe 
patients.4 We often see smokers who do not fulfill the COPD criteria on spirometry test 
(forced expiratory volume in 1 second [FEV1]/forced vital capacity [FVC] ,70%) but 
who suffer from COPD-like symptoms (eg, cough, sputum, dyspnea on effort) and/or 
have COPD-like findings on chest x-ray and/or computed tomography.5
There are few reports that have evaluated nutritional status of COPD-like   symptomatic 
elderly smokers compared with elderly COPD patients or healthy elderly. In the current 
study we compared anthropometrics, dietary intake, and nutritional status among elderly 
smokers with and without COPD diagnosis and healthy elderly controls.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Methods
study participants
Thirteen clinically diagnosed COPD patients, ten smokers 
with COPD-like symptoms but with FEV1/FVC . 70%, all 
of whom were current smokers with at least a 40 pack-year 
smoking history, and 27 never-smoking healthy controls were 
enrolled. All of them were males and 70 years old or older. 
Inclusion criteria for the COPD group and the symptomatic 
smokers (SYSM) group were having COPD-related 
symptoms (dyspnea on effort, cough, sputum), regardless of 
the existence of COPD-related image findings (chest X-ray 
hyperinflation, flattened diaphragm, low attenuation area, or 
bullous changes on high-resolution computed tomography 
for chest), no medication for COPD, and no participation in 
a rehabilitation program for the last 6 months. Patients were 
excluded if they had exacerbation, respiratory infection in 
the last 4 weeks, a history of chronic liver or renal failure, 
electrolyte abnormality, malignancy, insulin-dependent 
diabetes mellitus, usage of systemic corticosteroids, atopy, 
self-reported asthma, or reversibility .12% of airway 
obstruction after administration of a b2-agonist for asthma 
or clinically apparent heart failure. Atopic status was assessed 
by the negative history and the negative immunoglobulin 
E radioallergosorbent test to 26 common allergens. Due   
to the aforementioned exclusion criteria, 65 subjects were 
excluded (58 for respiratory infection in the last 4 weeks, 13 
for asthma diagnosis or complications, three for malignancy, 
one for heart failure). The study was approved by the scientific 
ethical committee of Kawasaki Medical School Hospital, and 
all patients gave informed consent.
study protocol
All subjects underwent a medical history taking and medical 
examination by an experienced pulmonologist, spirometry for 
measuring FEV1 and FEV1/FVC before and after broncho-
dilation, and biochemical blood tests, including analysis for 
albumin, prealbumin and transferrin, electrolytes, and renal 
and liver function. Anthropometry factors, resting energy 
expenditure (REE), and diet intake were evaluated.
Pulmonary function tests
Lung function was evaluated using a dry spirometer 
(CHESTAC-33; CHEST MI, Tokyo, Japan), which met the 
1994 American Thoracic Society recommendations for diag-
nostic spirometry. Three trials were performed, and the two 
higher inspiratory capacity values had to agree within 5% or 
60 mL.6 The patients with FEV1/FVC , 70% were classified to 
the COPD group, and patients with FEV1/FVC . 70% to the 
SYSM group. For calculation of spirometric “lung age” we used 
the Japanese Respiratory Society’s normal prediction equation 
for FEV1. The measured FEV1 and the patient’s height were sub-
stituted to calculate the functional age, which has been termed 
the “lung age” as follows: (0.036 × height (cm) - 1.178 - FEV1.0 
(L))/0.028. When the result was more than 95, “lung age” was 
set to 95 years old.7–9
Anthropometry assessment
Height, weight, percentage ideal body weight, body mass 
index (BMI) (calculated as weight/height squared), body 
fat percentage measured by bioelectrical impedance analysis 
(SS-103 Bio ImpemeterTM, Sekisui, Osaka, Japan), midupper 
arm muscle circumference (AMC), tricep skin fold thickness 
(TSF), and REE were measured. Predicted values were 
quoted from Japanese standardized data.10
Skin fold measurements were taken from the triceps and 
shoulder blade (subscaplar). The body fat percentage was 
estimated using the equations of Brozek et al.11 The equations 
for predicting body surface area (BSA), body density (D), 
and body fat percentage were as follows:
BSA = 72.46 × height ^ 0.725 × body weight ^ 0.425, 
D = 1.0923 - 0.000514 (the total of skin fold thickness 
of the back of the arm and shoulder blade × BSA/10,000/
body weight (kg) × 100, body fat percentage (%) = 
(4.570/D - 4.142) × 100.
For REE measurements, an indirect calorie meter was 
used (DeltatracTM; Datex Corp, Helsinki, Finland). All food, 
except for water or tea, was forbidden from 21:00 on the pre-
vious day. The REE was measured awake, in a resting state, 
and while in a supine position between 07:00 and 08:00. The 
device was calibrated each morning before use.
Diet intake assessment
Diet intake in a different 24 hours from the examination day 
was evaluated using a food value calculating software based 
on Japanese standard nutrition allowance surveillance data for 
intake energy, protein, fat, carbohydrate, vitamins, phosphorus, 
calcium, potassium, magnesium, iron, fiber, and sodium.11
statistical analysis
Data are presented as mean or median (95% confident 
interval [CI]). The statistical significance of differences 
among the three groups (control, SYSM, and COPD groups) 
was estimated with the Kruskal-Wallis test and analysis 
of   variance. The associations between the variables were 
determined using Spearman rank correlation analysis. The 
analysis was performed using statistical software (Stat International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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View 4.0; Abacus Concepts Co, Ltd, Baltimore, MD) and   
P , 0.05 was considered significant.
Results
Clinical characteristics of the subjects are shown in Table 1. 
Height and age were no different among the groups. The 
mean spirometric “lung age” of the control group was no 
different from their mean real age (80.2 [95% CI: 75.3 to 
85.1] vs 74.7 [70.3 to 79.1]). Symptomatic smokers had 
significantly lower FVC and %FVC than the control group 
(P , 0.001, respectively).
Anthropometry indexes are shown in Table 2. REE was 
no different among the groups. The SYSM group had sig-
nificantly lower weight, BMI, percentage ideal body weight, 
body fat percentage, AMC, and TSF than the control group 
did (P , 0.01 each), and all of them were similar to the 
COPD group.
Biochemical factors are shown in Table 3. Albumin, 
prealbumin, and transferrin in the SYSM and COPD groups 
were significantly lower than those in the control group 
(P , 0.02 each).
Diet intake assessment is shown in Table 4. Energy, 
vitamins (A, B1, B2, and C), calcium, iron, fiber, and sodium 
were significantly lower in the SYSM group than in the 
control group (P , 0.05 each), and they were similar to the 
COPD group, respectively.
In total, FEV1% predicted was positively correlated with 
iron, calcium, vitamin A, and vitamin B1 intake (P , 0.03 
each). In the SYSM and control groups, FEV1% predicted 
was not correlated with any factors. In the COPD group, 
FEV1% predicted was positively correlated with vitamin A 
(P = 0.03) and iron (P = 0.03) intake.
Discussion
We have found that elderly smokers who are symptomatic 
but who do not fulfill the COPD diagnostic criteria have 
nutritional deficits that may be related to insufficient energy 
intake similar to that seen in COPD patients.
From the late 1950s, it has been observed that many 
COPD patients have low body weight, which suggests it as 
an independent predictor for the mortality of the disease.12–17 
Subjects with COPD are known to have elevated respiratory 
consumption energy and REE compared with healthy 
  persons, and they intake less and thereby develop malnu-
trition or cachexia.18,19 Our study showed the nutritional 
similarities between the COPD patients who are known to be 
very sick and the symptomatic patients whom the clinicians 
may not recognize as being really sick.
Table 1 Clinical characteristics of the subjectsa
CONT group  
(n = 27)
SYSM group  
(n = 10)
P-value  
vs CONT
COPD group  
(n = 13)
P-value  
vs SYSM
P-value  
vs CONT
Age, year 73.0 [70.3, 79.1] 79.0 [72.2, 83.8] 0.38 78.5 [70.3, 81.7] 0.8333 0.77
height, cm 162.7 [160.8, 165.5] 165.2 [161.0, 167.6] 0.89 160.0 [155.9, 165.4] 0.5118 0.43
FeV1, L 2.4 [2.2, 2.5] 2.3 [1.8, 2.6] 0.68 1.0 [0.8, 1.3] ,0.0001 ,0.0001
FeV1/FVC ratio, % 87.2 [83.7, 91.8] 91.3 [81.9, 97.3] 0.42 36.3 [30.5, 42.1] ,0.0001 ,0.0001
FeV1% predicted, % 104.3 [97.8, 113.3] 104.9 [82.3, 124.7] 0.80 44.9 [37.7, 61.1] ,0.0001 ,0.0001
FVC, L 3.5 [2.8, 3.2] 2.6 [2.0, 3.0] 0.0003 2.9 [2.5, 3.3] 0.14 0.005
%FVC, % 110.7 [104.7, 117.2] 82.7 [64.3, 95.4] ,0.0001 87.8 [82.1, 105.2] 0.083 0.007
Lung age, year 78.7 [75.3, 85.1] 90.4 [79.5, 94.4] 0.241 95 0.113 0.0003
Note: aData are presented as median [95% confidence interval].
Abbreviations: COnT, control group; COPD, COPD patients; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; sYsM, symptomatic smokers.
Table 2 Anthropometry factors of the subjectsa
CONT group  
(n = 27)
SYSM group  
(n = 10)
P-value  
vs CONT
COPD group  
(n = 13)
P-value  
vs SYSM
P-value  
vs CONT
Weight, kg 62.2 [58.2, 66.3] 48.3 [42.6, 53.9] 0.0008 47.9 [41.1, 54.7] 0.435 0.0002
BMI, kg/m2 23.3 [22.1, 24.6] 17.8 [15.9, 19.6] ,0.0001 18.8 [16.5, 21.2] 0.65 ,0.0001
%IBW, % 105.5 [100.0, 111.1] 81.1 [73.2, 88.9] ,0.0001 84.1 [73.7, 94.4] 0.64 ,0.0001
Body fat percentage, % 22.0 [18.3, 25.7] 19.0 [16.2, 21.9] 0.009 21.1 [14.6, 27.7] 0.68 0.001
Arm muscle circumference, cm 391 [376, 406] 339 [280, 398] 0.012 346 [291, 401] 0.66 0.03
Triceps skin fold thickness, mm 14.6 [13.7, 15.4] 2.5 [2.0, 3.0] ,0.0001 2.9 [2.5, 3.3] 0.32 ,0.0001
resting energy expenditure, kcal 1015 [963, 1068] 971 [882, 1059] 0.11 997 [910, 1084] 0.26 0.78
Note: aData are presented as median [95% confidence interval].
Abbreviations: BMI, body mass index; COnT, control group; COPD, COPD patients; IBW, ideal body weight; sYsM, symptomatic smokers.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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The lower levels of BMI, TSF (an indicator of body fat 
deposition), AMC (an indicator of muscle volume), albumin, 
prealbumin, and transferrin in the SYSM group than in the 
healthy control group were similar to those of the COPD 
patients. However, REE levels were no different among the 
groups. The intake of energy, vitamins, calcium, iron, fiber, 
and sodium was significantly decreased in the SYSM and 
COPD subjects compared with the healthy controls. This 
may suggest that the nutrition decline of the subjects was not 
caused by REE increase but possibly by intake insufficiency. 
In the SYSM group, protein and fat intake insufficiency was 
noticeable. A study reported that a high carbohydrate diet 
accelerates the production of carbon dioxide and respiratory 
quotient.20 Therefore, a lower carbohydrate diet might 
prevent or improve subjects’ respiratory situation. Diet 
education may be important.21
In the study, iron and vitamin A intake was correlated 
with FEV1 predicted only in COPD groups, not in the SYSM 
or control groups. There are few reports about the iron nutri-
tion effect on lung function.22 For vitamin A and lung func-
tion, respiratory cell damage, as provoked by benzo[a]pyrene, 
which is present in cigarette smoke,23 decreases the uptake 
of vitamin A into lung cells24 and leads to a local vitamin 
A deficiency of the lung tissues.25 These data suggest that 
in patients with mild COPD, a local vitamin A deficiency 
can occur that induces pathophysiologic consequences 
such as narrowing of the lumina and loss of distensibil-
ity of the   airways.26 Paiva et al2 reported that   vitamin A 
Table 3 Biochemical factors of the subjectsa
CONT group  
(n = 27)
SYSM group  
(n = 10)
P-value  
vs CONT
COPD group  
(n = 13)
P-value  
vs SYSM
P-value  
vs CONT
Total protein, g/dL 7.1 [7.0, 7.3] 6.6 [6.1, 7.1] 0.007 6.9 [6.4, 7.3] 0.53 0.84
Albumin, g/dL 4.2 [4.0, 4.3] 3.7 [3.3, 4.0] ,0.0001 3.9 [3.7, 4.1] 0.09 0.0013
Total lymphocyte number/μL 1315 [1049, 1580] 1133 [758, 1507] 0.03 1646 [1362, 1929] 0.09 0.31
Choline esterase, IU/L 287 [264, 309] 209 [183, 234] ,0.0001 238 [198, 278] 0.01 0.11
Total cholesterol, mg/dL 202 [178, 226] 199 [152, 245] 0.99 187 [169, 206] 0.82 0.68
Prealbumin, mg/dL 31 [22, 40] 18.5 [10.6, 26.4] 0.012 27.4 [18.8, 26.0] 0.32 0.0005
Transferrin, mg/dL 245 [190, 300] 189 [134, 245] 0.001 202 [185, 219] 0.55 ,0.0001
hemoglobin, g/dL 13.6 [13.0, 14.3] 12.6 [11.7, 13.4] 0.003 13.5 [12.6, 14.5] 0.18 0.98
hematoclit, % 41.4 [39.3, 42.8] 37.0 [35.0, 39.0] 0.004 40.2 [37.1, 43.3] 0.015 0.83
Note: aData are presented as median [95% confidence interval].
Abbreviations: COnT, control group; COPD, COPD patients; sYsM, symptomatic smokers.
Table 4 Diet intake assessment for a daya
CONT group  
(n = 27)
SYSM group  
(n = 10)
P-value  
vs CONT
COPD group  
(n = 13)
P-value  
vs SYSM
P-value  
vs CONT
energy, kcal 1966 [1800, 2131] 1667 [1360, 1971] 0.015 1742 [1458, 2026] 0.58 0.048
energy/IBW*, kcal/kg 34.1 [30.5, 37.7] 28.0 [23.2, 32.7] 0.016 30.7 [25.7, 35.6] 0.31 0.17
Protein, g 74.4 [69.2, 79.6] 65.1 [53.8, 76.4] 0.053 61.4 [49.0, 73.8] 0.50 0.004
Protein/IBW, g/kg 1.27 [1.16, 1.39] 1.11 [0.94,1.28] 0.09 1.10 [0.88, 1.32] 0.99 0.049
Protein rate, % 15.3 [14.1, 16.4] 15.7 [14.3, 17.1] 0.64 14.5 [11.8, 17.1] 0.24 0.32
Fat, g 47.0 [40.7, 53.3] 35.5 [26.6, 44.4] 0.012 40.5 [27.5, 53.5] 0.39 0.09
Fat/IBW, g/kg 0.81 [0.70, 0.92] 0.61 [0.44, 0.78] 0.03 0.73 [0.47, 0.99] 0.31 0.27
Fat rate, % 22.0 [18.3, 25.7] 19.0 [16.2, 21.9] 0.15 21.1 [14.6, 27.7] 0.44 0.56
Carbon, g 273 [249, 298] 256 [214, 298] 0.32 247 [188, 306] 0.73 0.13
Carbon/IBW, g/kg 4.7 [4.3, 5.1] 4.3 [3.7, 4.9] 0.25 4.3 [3.3, 5.3] 0.95 0.24
Carbon rate, % 56.0 [51.2, 60.8] 61.8 [58.2, 65.5] 0.07 55.6 [48.3, 62.9] 0.06 0.69
Vitamin A, IU 3714 [3133, 4315] 369 [169, 569] ,0.0001 656 [0, 1416] 0.78 ,0.0001
Vitamin B1, mg 1.11 [0.98, 1.23] 0.81 [0.48, 1.15] 0.03 0.69 [0.40, 0.98] 0.40 0.001
Vitamin B2, mg 1.36 [1.19, 1.52] 0.95 [0.78, 1.11] 0.003 1.00 [0.70, 1.30] 0.71 0.005
Vitamin C, mg 175 [141, 208] 99 [44, 153] 0.010 96 [30, 162] 0.94 0.004
Calcium, mg 666 [564, 767] 455 [290, 619] 0.002 425 [306, 544] 0.695 0.002
Iron, g 11.9 [10.8, 13.1] 7.0 [4.4, 9.6] ,0.0001 5.7 [4.2, 7.1] 0.24 ,0.0001
Fiber, g 16.1 [13.8, 18.3] 11.5 [8.4, 14.6] 0.006 9.5 [6.6, 12.5] 0.30 ,0.0001
sodium, g 11.2 [10.1, 12.3] 9.3 [6.9, 11.7] 0.04 8.1 [5.8, 10.5] 0.42 0.002
Note: aData are presented as median [95% confidence interval].
Abbreviations: COnT, control group; COPD, COPD patients; IBW, ideal body weight; sYsM, symptomatic smokers.International Journal of COPD
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supplementation increased FEV1 in COPD. COPD is being 
recognized as a general disorder. Nutritional factors (iron 
and vitamin A) might be useful for early detection of COPD 
and general worsening.
The limitation of the study is that the subject number was 
very small. The target number of each group of the study was 
20 by statistic power. The expected positive and   negative 
rates were set as 80% and 40%, and for comparison of the 
difference of factors were set as half or double. The final 
omitted number was 65.
Although it is known that sarcopenia is the loss of 
muscle mass that happens to everyone with advancing age, 
our subjects were age matched, and the mean age was no 
different among the groups. Previous studies have already 
demonstrated that elderly COPD patients have higher REE 
compared with controls, but the subjects with moderate or 
more severe COPD, in contrast, in the smokers group in our 
study, did not have FEV1/FVC , 70%.16
Conclusion
Elderly smokers with COPD-like symptoms have insufficient 
energy intake, even if they do not have diagnosed COPD.
Disclosure
Funding was from the Kawasaki Medical School Fund.
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